About 10,000 baby boomers are turning 65 every day! The U.S. population is older today than it has ever been. Memory and physical challenges are commonly seen with age and frailty. This raises challenges for the person with the disability and their family members.  As per the CDC, one in five adults provided care or assistance to a friend or family member in the past 30 days. One in ten adults is providing care to a person with dementia. By 2050, the number of Americans living with dementia is expected to triple. The total lifetime cost of care for a patient with dementia is estimated to be $321,780 in 2015 dollars. Up to 89% of patients with dementia may develop delirium, which is an acute change in cognition and awareness and usually a sign of a new illness. The Worldwide Delirium market in 2022 was approximately $250M and is expected to double by 2030.
The market for delirium treatment includes various components such as pharmaceuticals, medical devices, and services aimed at diagnosing, managing, and preventing delirium. This market encompasses medications used to treat underlying causes of delirium, sedatives, antipsychotics, and other drugs to manage symptoms, as well as non-pharmacological interventions such as environmental modifications and cognitive therapies.